PCM - Pharma Consulting & Management GmbH > In-/Out-Licensing > Ethical > Propofol MCT/LCT - available for licensing

Ethical pharmaceuticals

Propofol MCT/LCT

Intravenously administered anaesthetic in a 1:1 emulsion mixture of medium- (MCT) and long-chain triglycerides (LCT).


Short acting intravenous general anaesthetic.

Pharmaceutical forms and presentations

Solution for intravenous application.

10 mg/ml, 20 ml ampoule and 50 ml vial,

20 mg/ml, 50 ml vial.


By intravenous bolus injection or continuous intravenous infusion.

Special feature

The mixture of medium- and long-chain triglycerides causes less pain at the site of injection, especially valuable in children.

Produced in

European Union.

Available countries

On request.


Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.